$WYGC
Longwen Group Corp. Stock $wygc

$wygc Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000101738623000306 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$548.9K	$1.204M	$6.808K
YoY Change	4745.08%	17579.98%
Cost Of Revenue	$550.1K	$1.087M
YoY Change
Gross Profit	-$1.265K	$116.4K	$6.808K
YoY Change	-111.17%	1609.94%
Gross Profit Margin	-0.23%	9.67%	100.0%
Selling, General & Admin	$125.8K	$127.4K	$73.06K
YoY Change	488.31%	74.39%	2556.8%
% of Gross Profit		109.45%	1073.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.340K	$3.222K	$572.00
YoY Change	376.69%	463.29%
% of Gross Profit		2.77%	8.4%
Operating Expenses	$187.6K	$236.5K	-$119.6K
YoY Change	265.01%	-297.68%	1740.26%
Operating Profit	-$189.1K	-$121.5K	-$113.0K
YoY Change	369.32%	7.5%
Interest Expense	-$100.00		$125.00
YoY Change	-180.0%
% of Operating Profit
Other Income/Expense, Net	-$170.00	-$186.00
YoY Change	54.55%
Pretax Income	-$189.1K
YoY Change	369.28%
Income Tax		$2.415K
% Of Pretax Income
Net Earnings	-$189.1K	-$123.9K	-$113.0K
YoY Change	369.32%	9.64%	-99.28%
Net Earnings / Revenue	-34.46%	-10.29%	-1660.11%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	79.83M shares	79.11M shares	65.70M shares
Diluted Shares Outstanding	79.83M shares	79.20M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.640K
YoY Change	-97.93%
Cash & Equivalents	$5.638K	$8.539K	$8.917K
Short-Term Investments
Other Short-Term Assets	$13.70K
YoY Change	-83.51%
Inventory	$39.30K	$39.57K
Prepaid Expenses	$13.70K	$53.66K	$93.86K
Receivables	$378.2K
Other Receivables	$0.00
Total Short-Term Assets	$436.8K	$555.9K	$102.8K
YoY Change	22.98%	440.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$250.4K	$255.1K	$6.924K
YoY Change	-6.92%	3584.01%
Goodwill	$1.132K	$1.132K	$993.00
YoY Change	14.0%	14.0%
Intangibles	$2.911K	$3.103K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$254.5K	$259.3K	$7.917K
YoY Change	-5.76%	3175.43%
TOTAL ASSETS
Total Short-Term Assets	$436.8K	$555.9K	$102.8K
Total Long-Term Assets	$254.5K	$259.3K	$7.917K
Total Assets	$691.3K	$815.2K	$110.7K
YoY Change	10.57%	636.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$483.1K	$436.5K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$230.2K
YoY Change	-20.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$713.3K	$651.8K	$91.89K
YoY Change	144.6%	609.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$713.3K	$651.8K	$91.89K
Total Long-Term Liabilities	$0.00
Total Liabilities	$713.3K	$651.8K	$91.89K
YoY Change	144.6%	609.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.96M	-$19.77M	-$18.44M
YoY Change	8.02%	7.23%
Common Stock	$7.983K	$7.983K	$6.577K
YoY Change	15.21%	21.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$22.04K	$163.4K	$18.81K
YoY Change
Total Liabilities & Shareholders Equity	$691.3K	$815.2K	$110.7K
YoY Change	10.57%	636.44%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$189.1K	-$123.9K	-$113.0K
YoY Change	369.32%	9.64%	-99.28%
Depreciation, Depletion And Amortization	$6.340K	$3.222K	$572.00
YoY Change	376.69%	463.29%
Cash From Operating Activities	-$96.35K
YoY Change	-65.11%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	85.59K
YoY Change	-85.17%
NET CHANGE
Cash From Operating Activities	-96.35K
Cash From Investing Activities	0.000
Cash From Financing Activities	85.59K
Net Change In Cash	-10.76K
YoY Change	-103.67%
FREE CASH FLOW
Cash From Operating Activities	-$96.35K
Capital Expenditures	$0.00
Free Cash Flow	-$96.35K
YoY Change	-66.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q2	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense		usd
	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards		usd
CY2023Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000723533
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	lwlw	Common Stock Issuable CommonStockIssuable		usd
CY2022Q4	lwlw	Deferred Compensation Sharebased DeferredCompensationSharebased		usd
CY2023Q2	lwlw	Online Product Sales OnlineProductSales		usd
CY2022Q2	lwlw	Online Product Sales OnlineProductSales		usd
CY2023Q2	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
CY2022Q2	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses		usd
CY2022Q2	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses		usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Loans ProceedsFromLoans		usd
	lwlw	Repayments Of Loans From Shareholder Loans RepaymentsOfLoansFromShareholderLoans		usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Acquisition Costs AcquisitionCosts		usd
	us-gaap	Notes Reduction NotesReduction		usd
CY2022Q2	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-11596
	dei	Entity Registrant Name EntityRegistrantName	LONGWEN GROUP CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-3506403
	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 25
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Caihe Rd
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Shangcheng Dist.
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hangzhou
	dei	Entity Address Country EntityAddressCountry	CN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	310000
	dei	City Area Code CityAreaCode	86 0571
	dei	Local Phone Number LocalPhoneNumber	85128985
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79825094	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8539	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68121	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	454102	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	39572	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	53656	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58413	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	555869	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	126534	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	255081	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3103	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3625	usd
CY2023Q2	us-gaap	Goodwill Goodwill	1132	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1132	usd
CY2023Q2	us-gaap	Assets Assets	815185	usd
CY2022Q4	us-gaap	Assets Assets	405661	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	436511	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31962	usd
CY2023Q2	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	114462	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	100802	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	90494	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	651775	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	134706	usd
CY2023Q2	us-gaap	Liabilities Liabilities	651775	usd
CY2022Q4	us-gaap	Liabilities Liabilities	134706	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79825094	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79825094	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	74108926	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	7983	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7411	usd
CY2023Q2	lwlw	Common Stock Issuable CommonStockIssuable	37	usd
CY2023Q2	lwlw	Deferred Compensation Sharebased DeferredCompensationSharebased	-74000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20002164	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19285539	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19770834	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19027835	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1940	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5840	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	163410	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	815185	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	405661	usd
CY2023Q2	lwlw	Consulting Service Income ConsultingServiceIncome	1978	usd
CY2022Q2	lwlw	Consulting Service Income ConsultingServiceIncome	6808	usd
	lwlw	Consulting Service Income ConsultingServiceIncome	15004	usd
	lwlw	Consulting Service Income ConsultingServiceIncome	7979	usd
	lwlw	Online Product Sales OnlineProductSales	6082	usd
CY2023Q2	lwlw	Offline Product Sales OfflineProductSales	1201675	usd
	lwlw	Offline Product Sales OfflineProductSales	1423276	usd
CY2023Q2	us-gaap	Revenues Revenues	1203653	usd
CY2022Q2	us-gaap	Revenues Revenues	6808	usd
	us-gaap	Revenues Revenues	1444362	usd
	us-gaap	Revenues Revenues	7979	usd
	lwlw	Online Product Sales Expenses OnlineProductSalesExpenses	2199	usd
CY2023Q2	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses	1087240	usd
	lwlw	Offline Product Sales Expenses OfflineProductSalesExpenses	1286396	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1087240	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1288595	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	116413	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	6808	usd
	us-gaap	Gross Profit GrossProfit	155767	usd
	us-gaap	Gross Profit GrossProfit	7979	usd
CY2023Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	33040	usd
CY2022Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	46555	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	106195	usd
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	81335	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127416	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	73062	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	211321	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	82802	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	76000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	576000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	236456	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	119617	usd
	us-gaap	Operating Expenses OperatingExpenses	893516	usd
	us-gaap	Operating Expenses OperatingExpenses	164137	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-120043	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-112809	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-737749	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-156158	usd
CY2023Q2	lwlw	Interest Expense1 InterestExpense1	-101	usd
CY2022Q2	lwlw	Interest Expense1 InterestExpense1	-203	usd
	lwlw	Interest Expense1 InterestExpense1	-156	usd
	lwlw	Interest Expense1 InterestExpense1	-328	usd
CY2023Q2	us-gaap	Other Income OtherIncome	-1351	usd
CY2022Q2	us-gaap	Other Income OtherIncome	-8	usd
	us-gaap	Other Income OtherIncome	-1836	usd
	us-gaap	Other Income OtherIncome	216	usd
CY2023Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1452	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-211	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1992	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-112	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-121495	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-113020	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-739741	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-156270	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2415	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3258	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-123910	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-113020	usd
	us-gaap	Net Income Loss NetIncomeLoss	-742999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-156270	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-9393	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-2580	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-7780	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-2098	usd
CY2023Q2	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	-9393	usd
CY2022Q2	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	-2580	usd
	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	-7780	usd
	us-gaap	Change In Reporting Entity Other Comprehensive Income Loss After Tax ChangeInReportingEntityOtherComprehensiveIncomeLossAfterTax	-2098	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-133303	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-115600	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-750779	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-158368	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79198916	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65704692	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78579905	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65438590	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Net Income Loss NetIncomeLoss	-742999	usd
	us-gaap	Net Income Loss NetIncomeLoss	-156270	usd
	us-gaap	Depreciation Depreciation	6527	usd
	us-gaap	Depreciation Depreciation	730	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	576000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	475249	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	41415	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2167	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	93859	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	426813	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	250	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-248156	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-249149	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7957	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	7	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7950	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	30378	usd
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	82107	usd
	us-gaap	Proceeds From Loans ProceedsFromLoans	134481	usd
	lwlw	Repayments Of Loans From Shareholder Loans RepaymentsOfLoansFromShareholderLoans	-29299	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-12990	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	67234	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	190725	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	189804	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	272832	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1230	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6816	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-59582	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8917	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68121	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8539	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8917	usd
	us-gaap	Acquisition Costs AcquisitionCosts	993	usd
	us-gaap	Notes Reduction NotesReduction	14050	usd
	us-gaap	Stock Issued1 StockIssued1	74000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	153479	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	76000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	67234	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9393	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-123910	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	163410	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	270955	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	576000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	67234	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7780	usd
	us-gaap	Profit Loss ProfitLoss	-742999	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	163410	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	59769	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	74638	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2580	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-113020	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18807	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-13550	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	190725	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2098	usd
	us-gaap	Profit Loss ProfitLoss	-156270	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18807	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 750
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	127061	shares
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	66667	shares
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	65000000	shares
CY2022Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	1000	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	993	usd
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	1000
CY2022Q4	us-gaap	Acquisition Costs AcquisitionCosts	141	usd
CY2022Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	139	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	6527	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	730	usd
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.20
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zOFZjWAuw0vg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-32817	usd
CY2023Q2	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	26021	usd
CY2022Q2	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	23734	usd
	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	156030	usd
	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	32817	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_z2Pt9mYBoppj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Concentration</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended June 30, 2023, the Company generated 61%, 19% and 15% of revenues from the top 3 customers, respectively. During the six months ended June 30, 2023, the Company generated 62%, 20% and 12% of revenues from the top 3 customers, respectively. The Company’s cost of revenues consisted of 97% and 92% purchases from one top vendor for the three and six months ended June 30, 2023, respectively. The Company’s revenue and cost of revenues were not material during the three and six months ended June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79825094	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	74108926	shares
	us-gaap	Net Income Loss NetIncomeLoss	-742999	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19770834	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7057	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7419	usd
CY2023Q2	us-gaap	Land Land	258070	usd
CY2022Q4	us-gaap	Land Land	271319	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10046	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4368	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	255081	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	274370	usd
	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2651780	shares
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	265178	usd
CY2023Q2	lwlw	Value Added Tax Payable ValueAddedTaxPayable	2108	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	263070	usd
CY2023Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	3222	usd
CY2022Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	587	usd
CY2023Q2	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	114462	usd
CY2022Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12250	usd
CY2019Q4	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	300	usd
CY2023Q1	us-gaap	Notes Reduction NotesReduction	14050	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	125	usd
	us-gaap	Interest Expense InterestExpense	250	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	-12990	usd
	lwlw	Repayments Of Loans From Third Parties RepaymentsOfLoansFromThirdParties	90000
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19800000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19000000.0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	787005	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	630975	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	787005	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	630975	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-26021	usd
CY2022Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23734	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-156030	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10000000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4250000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	425000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	750000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	200000	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	550000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	180000	shares
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	74000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	370000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5000000	shares
CY2023Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	7789	usd

Files In Submission

Name	View Source	Status
0001017386-23-000306-index-headers.html	Edgar Link	pending
0001017386-23-000306-index.html	Edgar Link	pending
0001017386-23-000306.txt	Edgar Link	pending
0001017386-23-000306-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lwlw-20230630.xsd	Edgar Link	pending
lwlw_2023jun30-10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
lwlw-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lwlw-20230630_cal.xml	Edgar Link	unprocessable
lwlw-20230630_pre.xml	Edgar Link	unprocessable
lwlw-20230630_lab.xml	Edgar Link	unprocessable
lwlw_2023jun30-10q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WYGC
Longwen Group Corp. Stock $wygc

2023 Q3 Form 10-Q Financial Statement

#000101738623000306 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC Longwen Group Corp. Stock $wygc

2023 Q3 Form 10-Q Financial Statement

#000101738623000306 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYGC
Longwen Group Corp. Stock $wygc